PMID- 15712014 OWN - NLM STAT- MEDLINE DCOM- 20050421 LR - 20181113 IS - 0093-7711 (Print) IS - 0093-7711 (Linking) VI - 56 IP - 11 DP - 2005 Feb TI - HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. PG - 798-807 AB - Measles virus-specific T cells and the production of cytokines play a critical role in the immune response following measles immunization. To understand the genetic factors that influence variation in IFN-gamma and IL-4 responses following measles immunization and to provide insight into the factors influencing both cellular and humoral immunity to measles, we assessed associations between human leukocyte antigen (HLA) class II genes and measles-specific Th1 and Th2-type cytokine responses in peripheral blood lymphocytes from 339 children previously vaccinated with two doses of measles-mumps-rubella vaccine (MMR-II). Median values for measles-specific IFN-gamma and IL-4 secretion levels were 40.73 and 9.71 pg/ml, respectively. The global tests suggested associations between measles-specific IFN-gamma response and alleles of the DRB1 and DQB1 loci (P=0.07 and P=0.02, respectively). Specifically, DRB1*0301, *0901, and *1501 alleles were significantly associated with IFN-gamma secretion. The alleles that suggested evidence of an HLA association with IL-4 secretion were DRB1*0103, *0701, and *1101. Th1 cytokine responses and DQB1 allele associations revealed that the alleles with the strongest association with IFN-gamma secretion were DQB1*0201, *0303, *0402, and *0602. Specific alleles with a suggestive association with low measles-specific Th2 cytokine responses were DQB1*0202 and *0503. In addition, DPB1*0101, *0201, and *0601 alleles provided suggestive evidence of an HLA association with measles-induced IFN-gamma response, while DPB1*0501 was associated with an IL-4 response. These data suggest that IFN-gamma and IL-4 cytokine responses to measles may be genetically restricted in part by HLA class II genes, which in turn can restrict the cellular immune response to measles vaccine. FAU - Ovsyannikova, Inna G AU - Ovsyannikova IG AD - Mayo Vaccine Research Group, Mayo Clinic and Foundation, Guggenheim 611C, 200 1st Street SW, Rochester, MN 55905, USA. FAU - Jacobson, Robert M AU - Jacobson RM FAU - Ryan, Jenna E AU - Ryan JE FAU - Vierkant, Robert A AU - Vierkant RA FAU - Pankratz, V Shane AU - Pankratz VS FAU - Jacobsen, Steven J AU - Jacobsen SJ FAU - Poland, Gregory A AU - Poland GA LA - eng GR - AI 33144/AI/NIAID NIH HHS/United States GR - AI 48793/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. DEP - 20050127 PL - United States TA - Immunogenetics JT - Immunogenetics JID - 0420404 RN - 0 (Cytokines) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (Measles Vaccine) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Adolescent MH - Child MH - Cytokines/immunology/*metabolism MH - Female MH - Histocompatibility Antigens Class II/*immunology MH - Humans MH - Immune System/*drug effects/immunology/metabolism MH - Interferon-gamma/immunology/metabolism MH - Male MH - Measles Vaccine/immunology/*pharmacology MH - Measles virus/immunology EDAT- 2005/02/16 09:00 MHDA- 2005/04/22 09:00 CRDT- 2005/02/16 09:00 PHST- 2004/08/13 00:00 [received] PHST- 2004/11/17 00:00 [revised] PHST- 2005/02/16 09:00 [pubmed] PHST- 2005/04/22 09:00 [medline] PHST- 2005/02/16 09:00 [entrez] AID - 10.1007/s00251-004-0756-0 [doi] PST - ppublish SO - Immunogenetics. 2005 Feb;56(11):798-807. doi: 10.1007/s00251-004-0756-0. Epub 2005 Jan 27.